# EDGAR Filing Document

**Accession Number:** 0001907884
**File Stem:** 0001085146-25-005611
**Filing Date:** 2025-8
**Character Count:** 41438
**Document Hash:** 2592642b893103f8e2c64e02e91ce206
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001085146-25-005611.hdr.sgml**: 20250829

**ACCESSION NUMBER**: 0001085146-25-005611

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250829

**EFFECTIVENESS DATE**: 20250829

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Kynam Capital Management, LP
- **CENTRAL INDEX KEY:** 0001907884

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-21939
- **FILM NUMBER:** 251277644

**BUSINESS ADDRESS:**
- **STREET 1:** 221 ELM ROAD
- **CITY:** PRINCETON
- **STATE:** NJ
- **ZIP:** 08540
- **BUSINESS PHONE:** 212-659-3970

**MAIL ADDRESS:**
- **STREET 1:** 221 ELM ROAD
- **CITY:** PRINCETON
- **STATE:** NJ
- **ZIP:** 08540

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001907884

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Kynam Capital Management, LP

**Address:** 221 ELM ROAD, PRINCETON, NJ 08540

**Telephone number:** 646-753-2832

**Name of agent for service:** Jared Keller

**Agent Address:** 221 ELM ROAD, PRINCETON, NJ 08540

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-21939

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** 5493001IFQG42YBOK349

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                   | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| Wave Life Sciences Ltd.          | Y95308105 | 08/06/2024     | To approve our payment of cash and equity-based compensation to non-employee directors for service on the Board of Directors and its committees, in the manner and on the basis set forth under"Proposal 3: Non-Employee Directors' Compensation" in the proxy statement                                                                                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |        3932550 |                0 | FOR         |                                  3932550 | FOR                         |  |
| Wave Life Sciences Ltd.          | Y95308105 | 08/06/2024     | To approve a proposed amendment to our 2021 Equity Incentive Plan, as amended, in the manner and on the basis as set forth under "Proposal 4: Approval of an Amendment to the 2021 Equity Incentive Plan, as amended" in the proxy statement                                                                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |        3932550 |                0 | FOR         |                                  3932550 | FOR                         |  |
| Wave Life Sciences Ltd.          | Y95308105 | 08/06/2024     | To authorize the Board of Directors to allot and issue Ordinary Shares of Wave Life Sciences Ltd.                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |        3932550 |                0 | FOR         |                                  3932550 | FOR                         |  |
| Wave Life Sciences Ltd.          | Y95308105 | 08/06/2024     | To approve, by a non-binding advisory vote, the compensation of our named executive officers as disclosed in the proxy statement                                                                                                                                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |        3932550 |                0 | FOR         |                                  3932550 | FOR                         |  |
| Nurix Therapeutics, Inc.         | 00067080M | 05/18/2025     | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement                                                                                                                                                                                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |          18947 |                0 | WITHOLD     |                                    18947 | NONE                        |  |
| Syndax Pharmaceuticals, Inc.     | 00087164F | 05/14/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2025 proxy statement.                                                                                                                                                                                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |        7541277 |                0 | FOR         |                                  7541277 | FOR                         |  |
| Traverre Therapeutics, Inc.      | 00089422G | 05/15/2025     | To approve the Company's 2018 Equity Incentive Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by 4,000,000 shares.                                                                                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |        1716881 |                0 | WITHOLD     |                                  1716881 | NONE                        |  |
| Traverre Therapeutics, Inc.      | 00089422G | 05/15/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |        1716881 |                0 | WITHOLD     |                                  1716881 | NONE                        |  |
| Vera Therapeutics, Inc.          | 00092337R | 05/14/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement                                                                                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |        1493208 |                0 | WITHOLD     |                                  1493208 | NONE                        |  |
| Vera Therapeutics, Inc.          | 00092337R | 05/14/2025     | To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |        1493208 |                0 | WITHOLD     |                                  1493208 | NONE                        |  |
| Immunocore Holdings PLC          | 00045258D | 05/15/2025     | To approve our directors' remuneration report for the year ended December 31, 2024, which is set forth as Annex A to the proxy statement and on pages 22 to 49 of the 2024 U.K. Annual Report (excluding the director's remuneration policy set out on pages A-5 to A-15 of Annex A).                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |         834479 |                0 | WITHOLD     |                                   834479 | NONE                        |  |
| Immunocore Holdings PLC          | 00045258D | 05/15/2025     | To approve the directors' remuneration policy, which is set for on pages A-5 to A-15 of Annex A to the proxy statement, which will take effect immediately after the end of the AGM.                                                                                                                                                                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |         834479 |                0 | WITHOLD     |                                   834479 | NONE                        |  |
| Immunocore Holdings PLC          | 00045258D | 05/15/2025     | To authorize the directors of the Company, generally and unconditionally for the purpose of section 551 of the Companies Act, to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company (“Share Rights”) up to an aggregate nominal amount of £150,000 for a period expiring (unless previously renewed, varied or revoked) on May 14, 2030, save that the Company may,.... (due to space limits, see proxy material for full proposal).                                                              | SECTION 14A SAY-ON-PAY VOTES |         834479 |                0 | WITHOLD     |                                   834479 | NONE                        |  |
| Immunocore Holdings PLC          | 00045258D | 05/15/2025     | Subject to the passing of resolution 12, to empower the directors of the Company generally pursuant to section 570(1) and section 573 of the Companies Act to allot equity securities (as defined in section 560 of the Companies Act) for cash pursuant to the general authority conferred on them by resolution 12 as if section 561(1) of the Companies Act did not apply to the allotment. This power: a. shall be limited to the ... (due to space limits, see proxy material for full proposal).                                                               | SECTION 14A SAY-ON-PAY VOTES |         834479 |                0 | WITHOLD     |                                   834479 | NONE                        |  |
| Geron Corporation                | 000374163 | 05/21/2025     | To approve an amendment to our 2018 Equity Incentive Plan to, among other items, increase the total number of shares of our common stock issuable thereuner by 20,000,000 shares.                                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |        3267895 |                0 | WITHOLD     |                                  3267895 | NONE                        |  |
| Geron Corporation                | 000374163 | 05/21/2025     | To approve an amendment to our 2014 Employee Stock Purchase Plan to increase the number of shares of our common stock issuable thereunder by 6,000,000 shares.                                                                                                                                                                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |        3267895 |                0 | WITHOLD     |                                  3267895 | NONE                        |  |
| Geron Corporation                | 000374163 | 05/21/2025     | To approve, on an advisory basis, the compensation of our Named Executive Officers, as disclosed in our Proxy Statement.                                                                                                                                                                                                                                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |        3267895 |                0 | WITHOLD     |                                  3267895 | NONE                        |  |
| Amarin Corporation PLC           | 000023111 | 05/13/2025     | Ordinary resolution to hold an advisory (non-binding) vote to approve the compensation of the Company's "named executive officers" as described in full in the "Executive Compensation Discussion and Analysis" section, the tabular disclosure regarding such compensation, and the accompanying narrative disclosure on pages 26 to 58 of the accompanying Proxy Statement.                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |        9501969 |                0 | WITHOLD     |                                  9501969 | NONE                        |  |
| Amarin Corporation PLC           | 000023111 | 05/13/2025     | Ordinary resolution to generally and unconditionally authorize the Board of Directors of the Company (the "Board") to allot shares in the Company or grant rights to subscribe for or to convert any security into shares of the Company up to an aggregate nominal amount of £38,400,000 (which is equal to approximately 18% of the existing issued share capital) as described in full on pages 13 to 14 of the accompanying Proxy Statement.                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |        9501969 |                0 | WITHOLD     |                                  9501969 | NONE                        |  |
| Amarin Corporation PLC           | 000023111 | 05/13/2025     | Special resolution to give power to the Board, subject to the passing of Resolution No. 11 above and in accordance with Section 570 of the Companies Act 2006, to allot equity securities (as defined in Section 560 of the Companies Act) pursuant to the authority conferred upon them by Resolution No. 11, as if Section 561(1) of the Companies Act did not apply to any such allotment, provided that the power hereby conferred shall (a) be limited to the allotment of equity securities up ...(due to space limits, see proxy material for full proposal). | SECTION 14A SAY-ON-PAY VOTES |        9501969 |                0 | WITHOLD     |                                  9501969 | NONE                        |  |
| Dynavax Technologies Corporation | 000268158 | 06/11/2025     | To approve, on an advisory basis, executive compensation for certain of our executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |        1496901 |                0 | FOR         |                                  1496901 | FOR                         |  |
| Cogent Biosciences, Inc.         | 00019240Q | 06/04/2025     | Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |        6690128 |                0 | WITHOLD     |                                  6690128 | NONE                        |  |
| Relay Therapeutics, Inc.         | 00075943R | 06/06/2025     | To consider and act upon an advisory vote on the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |        1031265 |                0 | WITHOLD     |                                  1031265 | NONE                        |  |
| Biocryst Pharmaceuticals, Inc.   | 00009058V | 06/12/2025     | To hold a non-binding, advisory vote regarding executive compensation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |        6139755 |                0 | FOR         |                                  6139755 | FOR                         |  |
| Biocryst Pharmaceuticals, Inc.   | 00009058V | 06/12/2025     | To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan.                                                                                                                                                                                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |        6139755 |                0 | FOR         |                                  6139755 | FOR                         |  |
| Celldex Therapeutics, Inc.       | 00015117B | 06/05/2025     | To approve an amendment to our 2021 Omnibus Equity Incentive Plan, including an increase in the number of shares reserved for issuance thereunder by 2,000,000 shares to 9,500,000 shares.                                                                                                                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |        4605007 |                0 | WITHOLD     |                                  4605007 | NONE                        |  |
| Celldex Therapeutics, Inc.       | 00015117B | 06/05/2025     | To approve, on an advisory basis, the compensation of the Company's Named Excutive Officers as disclosed in the Proxy Statement.                                                                                                                                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |        4605007 |                0 | WITHOLD     |                                  4605007 | NONE                        |  |
| Beam Therapeutics Inc.           | 00007373V | 06/04/2025     | Approve, on an advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         291041 |                0 | WITHOLD     |                                   291041 | NONE                        |  |
| Sutro Biopharma, Inc.            | 000869367 | 06/05/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |        3684133 |                0 | WITHOLD     |                                  3684133 | NONE                        |  |
| Vaxcyte, Inc.                    | 00092243G | 06/12/2025     | Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |        1305590 |                0 | FOR         |                                  1305590 | FOR                         |  |
| Viridian Therapeutics, Inc.      | 00092790C | 06/20/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |        3477428 |                0 | FOR         |                                  3477428 | FOR                         |  |
| Viridian Therapeutics, Inc.      | 00092790C | 06/20/2025     | To approve a further amendment and restatement of the Company's Amended and Restated 2016 Equity Incentive Plan, including increasing the number of shares available for issuance thereunder by 8,000,000 shares.                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |        3477428 |                0 | FOR         |                                  3477428 | FOR                         |  |
| Viridian Therapeutics, Inc.      | 00092790C | 06/20/2025     | To approve the Viridian Therapeutics, Inc.2025 Employee Stock Purchase Plan.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |        3477428 |                0 | FOR         |                                  3477428 | FOR                         |  |
| Oxford Nanopore Technologies PLC | 9EQ74ZCQ7 | 06/04/2025     | TO RECEIVE AND APPROVE THE DIRECTORS REMUNERATION REPORT EXCLUDING THE DIRECTORS REMUNERATION POLICY FOR THE YEAR ENDED 31 DECEMBER 2024                                                                                                                                                                                                                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |        4934050 |                0 | WITHOLD     |                                  4934050 | NONE                        |  |
| Oxford Nanopore Technologies PLC | 9EQ74ZCQ7 | 06/04/2025     | TO RECEIVE AND APPROVE THE DIRECTORS REMUNERATION POLICY THE FULL TEXT OF WHICH IS SET OUT ON PAGES 130 TO 139 OF THE ANNUAL REPORT AND ACCOUNTS                                                                                                                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |        4934050 |                0 | WITHOLD     |                                  4934050 | NONE                        |  |
| Oxford Nanopore Technologies PLC | 9EQ74ZCQ7 | 06/04/2025     | TO AUTHORISE THE BOARD OF DIRECTORS TO ALLOT SHARES                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |        4934050 |                0 | WITHOLD     |                                  4934050 | NONE                        |  |
| Oxford Nanopore Technologies PLC | 9EQ74ZCQ7 | 06/04/2025     | TO DISAPPLY PRE-EMPTION RIGHTS SUBJECT TO APPROVED LIMITS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |        4934050 |                0 | WITHOLD     |                                  4934050 | NONE                        |  |
| Oxford Nanopore Technologies PLC | 9EQ74ZCQ7 | 06/04/2025     | TO FURTHER DISAPPLY PRE-EMPTION RIGHTS SUBJECT TO APPROVED LIMITS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |        4934050 |                0 | WITHOLD     |                                  4934050 | NONE                        |  |
| Oxford Nanopore Technologies PLC | 9EQ74ZCQ7 | 06/04/2025     | TO AUTHORISE UK POLITICAL EXPENDITURE NOT EXCEEDING 100000 POUNDS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |        4934050 |                0 | WITHOLD     |                                  4934050 | NONE                        |  |
| Natera, Inc.                     | 000632307 | 06/12/2025     | To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement.                                                                                                                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          17082 |                0 | WITHOLD     |                                    17082 | NONE                        |  |
| Natera, Inc.                     | 000632307 | 06/12/2025     | To approve an amendment to Natera's Amended and Restated 2015 Equity Incentive Plan.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |          17082 |                0 | WITHOLD     |                                    17082 | NONE                        |  |
| Ironwood Pharmaceuticals, Inc.   | 00046333X | 06/10/2025     | Approval, by non-binding advisory vote, of the compensation paid to the named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |        5650928 |                0 | WITHOLD     |                                  5650928 | NONE                        |  |
| Cullinan Therapeutics, Inc.      | 000230031 | 06/12/2025     | Proposal to vote, on an advisory basis, to approve our named executive officer compensation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |        1417426 |                0 | WITHOLD     |                                  1417426 | NONE                        |  |
| Cullinan Therapeutics, Inc.      | 000230031 | 06/12/2025     | Proposal to vote, on an advisory basis, on the frequency of future advisory votes on our named executive officer compensation.                                                                                                                                                                                                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |        1417426 |                0 | WITHOLD     |                                  1417426 | NONE                        |  |
| Edgewise Therapeutics Inc.       | 00028036F | 06/13/2025     | Conduct an advisory vote on the compensation of our named ecexutive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |         270219 |                0 | WITHOLD     |                                   270219 | NONE                        |  |
| Edgewise Therapeutics Inc.       | 00028036F | 06/13/2025     | Conduct an advisory vote on the frequency of future advisory votes on the compensation of ou rnamed executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         270219 |                0 | WITHOLD     |                                   270219 | NONE                        |  |
| Engene Holdings Inc.             | 00029286M | 06/05/2025     | To consider, and if deemed advisable, pass an ordinary resolution approving a proposal to adopt the enGene Holdings Inc. 2025 Employee Stock Purchase Plan described in the Proxy Statement.                                                                                                                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |        4994090 |                0 | WITHOLD     |                                  4994090 | NONE                        |  |
| Liquidia Corporation             | 00053635D | 06/17/2025     | To approve, on an advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |         424712 |                0 | WITHOLD     |                                   424712 | NONE                        |  |
| Ideaya Biosciences, Inc.         | 00045166A | 06/24/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders.                                                                                                                                                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |          14431 |                0 | WITHOLD     |                                    14431 | NONE                        |  |

## N-PX: Signature Block

**Reporting Person:** Kynam Capital Management, LP

**By (Signature):** Jared Keller

**By (Printed Signature):** Jared Keller

**By (Title):** COO

**Date:** 08/29/2025